Metagenomic Analysis Reveals Gut Microbiota Features in Membranous Nephropathy

Area of Science:

• Nephrology
• Microbiome Research
• Gut-Kidney Axis

Background:

• Membranous nephropathy (MN) is a leading cause of glomerulonephritis globally, associated with immune system dysfunction.
• The gut microbiota influences kidney health via the gut-renal axis, but its role in MN is understudied.

Purpose of the Study:

• To investigate gut microbiota composition and function in patients with membranous nephropathy (MN) using metagenomic sequencing.
• To identify specific microbial alterations and their correlation with clinical parameters in MN.

Main Methods:

• Shotgun metagenomic sequencing of fecal samples from 10 MN patients and 10 healthy controls.
• Analysis of microbial diversity, taxonomic composition, functional pathways (KEGG), and correlations with clinical indicators.

Main Results:

• Distinct gut microbial differences were observed in MN patients, with increased abundance of Proteobacteria, Firmicutes_C, Cyanobacteria, and specific genera/species.
• Correlations found between specific bacteria (e.g., Bacillus_A, Victivallis, Fusicatenibacter) and clinical markers (serum creatinine, BUN, phospholipase A2 receptor levels).
• Enrichment of pathways in tryptophan metabolism, oxidative phosphorylation, and E. coli infection noted; a four-genus model showed diagnostic potential (AUC=0.90).

Conclusions:

• Gut microbiota composition and function are altered in MN patients.
• Findings suggest an association between gut dysbiosis and MN, highlighting potential biomarkers.
• Further research is needed to confirm these associative findings and explore biological relevance.